Search Results

LY341495 10mg 10mg  | Purity Not Available

Adooq Bioscience

LY 341495 has been shown to be a highly potent and selective group II metabotropic glutamate receptor (mGluR-2) antagonist with Ki / IC50 values are 2.3, 1.3, 173, 990, 6800, 8200 and 22000 nM for human mGluR-2, mGluR-3, mGluR-8 , mGluR-7a, mGluR-1a, mGluR-5a and mGluR-4a.

More Information Supplier Page

Laropiprant 50mg 50mg  | Purity Not Available

Adooq Bioscience

Laropiprant is used in combination with niacin to reduce blood cholesterol. Laropiprant acts as a DP1 antagonist, reducing the vasodilation.

More Information Supplier Page

Laropiprant 5mg 5mg  | Purity Not Available

Adooq Bioscience

Laropiprant is used in combination with niacin to reduce blood cholesterol. Laropiprant acts as a DP1 antagonist, reducing the vasodilation.

More Information Supplier Page

Laropiprant 25mg 25mg  | Purity Not Available

Adooq Bioscience

Laropiprant is used in combination with niacin to reduce blood cholesterol. Laropiprant acts as a DP1 antagonist, reducing the vasodilation.

More Information Supplier Page

KX2-391 dihydrochloride 5mg 5mg  | Purity Not Available

Adooq Bioscience

KX2-391 2Hcl is the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

More Information Supplier Page

KX2-391 dihydrochloride 25mg 25mg  | Purity Not Available

Adooq Bioscience

KX2-391 2Hcl is the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

More Information Supplier Page

KX2-391 dihydrochloride 10mg 10mg  | Purity Not Available

Adooq Bioscience

KX2-391 2Hcl is the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

More Information Supplier Page

Iguratimod (T 614) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Iguratimod(T 614) is one of a series of 4H-1-benzopyran-4-ones which has potent anti-inflammatory, analgesic and antipyretic activity. Iguratimod(T 614) is a selective inhibitor of cyclo-oxygenase-2 (COX-2), and inhibits the production of interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor.

More Information Supplier Page

Iguratimod (T 614) 5mg 5mg  | Purity Not Available

Adooq Bioscience

Iguratimod(T 614) is one of a series of 4H-1-benzopyran-4-ones which has potent anti-inflammatory, analgesic and antipyretic activity. Iguratimod(T 614) is a selective inhibitor of cyclo-oxygenase-2 (COX-2), and inhibits the production of interleukin-1 (IL-1), IL-6, IL-8 and tumour necrosis factor.

More Information Supplier Page